Clinical Trial Update: A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of levoketoconazole for endogenous Cushing's syndrome has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endogenous Cushing Syndrome

Drugs mentioned

• levoketoconazole (levoketoconazole)

Snippet

Sponsor: Cortendo AB | Conditions: Endogenous Cushing's Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2022-11-08